ProStrakan

ProStrakan confident of US approval for key drug THE chief executive of one of Scotland's specialist drug companies has predicted that its latest hormone-based product will win approval from US regulators.

ProStrakan rejects merger offers as hungry biotechs hunt out cash PROSTRAKAN has been approached for mergers from cash-strapped biotech companies from both sides of the Atlantic as the industry suffers from a major low in investor confidence.

More Stories

Include [3]

Include [2]

Include [1]

Include [6]

Include [5]

Include [4]

Include [9]

Include [8]

Include [7]

Home Back to content Sitemap Contact Us

Also Search

Featured Advertising

Johnston Press Digital Publishing

Sister Newspapers:

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.

Sections

Other Sections

Topics

Other Sites

ProStrakan

More Stories